Navigation Links
Alimera Sciences Closes $5 Million in Extended Series C Financing
Date:8/27/2009

ATLANTA, Aug. 27 /PRNewswire/ -- Alimera Sciences, Inc., today announced that it has closed a $5 million extension of its Series C financing which was originally completed in March 2008. In connection with this financing, the purchasers of the $5 million in Series C preferred stock received warrants for an additional $10 million in Series C preferred stock. The warrant holders will have up to 30 days from the delivery of Phase III top-line data for Iluvien(R) to elect to exercise the warrants. If the majority of the holders of warrants make such election, then all warrant holders will be required to exercise their warrants in full. Alimera expects to receive the Phase III top-line data for Iluvien in December of this year.

Iluvien is an investigative, extended release intravitreal insert that Alimera is developing for the treatment of diabetic macular edema (DME). Currently, nearly 24 million people, or 8 percent of the population, in the U.S. have diabetes. Over time, all diabetics are at risk of developing DME. Based on published data, Alimera estimates that there are as many as 300,000 new cases of DME each year and 1,000,000 people have DME. There are no ophthalmic drug therapies currently approved by the U.S. Food and Drug Administration for the treatment of this disease.

Each Iluvien insert is designed to provide a sustained therapeutic effect of up to 36 months, for the low dose of Iluvien, and up to 24 months, for the high dose of Iluvien. Iluvien is inserted into the patient's eye with a 25-gauge needle, which allows for a self-sealing wound. This insertion is very similar to an intravitreal injection, a procedure commonly employed by retinal specialists.

About Alimera Sciences Inc.

Alimera Sciences is a biopharmaceutical company that specializes in the research, development and commercialization of pre
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD
2. Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement
3. Regado Biosciences Announces First Patient Enrolled In Phase 1 Study Of Subcutaneously Administered Reg1 Anticoagulation System
4. Biosciences Firm Chooses CloudCraze for eCommerce Business Solution -- LI-COR and EDL Consulting Take Expertise into the "Cloud"
5. PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry
6. Cryo-Cell Announces Strategic Partnership With S-Evans Biosciences, Inc.
7. BP and Martek Biosciences Enter Joint Development Agreement to Deliver Advanced Biodiesels
8. Advanced Life Sciences Announces Second Quarter 2009 Financial Results and Financial Outlook
9. BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels
10. Ingenuitys Technology Powers BD Cell Pathways Tool on New BD Biosciences Website
11. YM BIOSCIENCES USA RECEIVES CLEARANCE FROM US TREASURY DEPARTMENT TO EXTEND CLINICAL PROGRAM FOR NIMOTUZUMAB

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e/--BiotechfirmReplikinsLtd.,whichhasanalyzedtheH1...ediction,outbreak,andprogressofthecurrentH1N1pande...rus.ThenewdatashowsthatthelethalityoftheH1N1("Swin...ngthevirus,scurrentoutbreakinthespringof2009torest...1virus,infectivitycount,however,remainsincreased. ...
(Date:11/25/2009)...re-Asia/--SinovacBiotechLtd.(SVA),aleadingdevelop...ed,ajointventure(JV)agreementtoestablishSinovac(Da...JVwillresearch,develop,produce,andcommercializehum...ndexperienceindevelopingandcommercializingworld-cl...s,manufacturingfacilitiesand,establishedoperatingi...
(Date:11/24/2009)...re-FirstCall/--IES(Nasdaq: IESC ),aleadingnational...vicesforthecommercial,industrialandresidentialmark...sbeenawardedacontractfromManhattanTorconJVtoinstal...-4)replacementfacilityattheU.S.ArmyMedicalResearch...ckinFrederick,Md. ,, ThenewUSAMRIIDreplacementf...
(Date:11/24/2009)...rio,Nov.24/PRNewswire-FirstCall/--DowAgroSciencesC...eeds,adivisionofThompsonsLimitedofBlenheim,Ontario...ciences,currentseedsbusinessasthecompanyanticipate...groSciencesHerbicideTolerantTraitTechnologyincorni...re. ,, "Thisacquisitionbringstogethertwostrongp...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...matrix, Inc. today,announced that on April 22, 200...al Ben Franklin Emerging Business Awards, known as...ent Team category, competing with a,strong group o...a region.,BioNanomatrix chief executive officer Dr...f of the company., The Bennies, co-founded in 199...
...rWatch.biz announces the,availability of MarketSta...ets today within the biotechnology and diagnostic ... the aforementioned equities and the,opportunity f... on the,subject and sector., Investors can view S...w.SectorWatch.biz -- a division of financial news...
...roduct to 32,000+ healthcare providers, PRINCETON...n Board: DSCI), a provider of advanced wound care,... multi-year supply,agreement with one of the natio...ts Supply Chain Systems, a MedAssets company (Nasd...ve date of June 1, 2008, will help to,introduce ME...
Other Biology Technology:BioNanomatrix Named 'Best Management Team' at the 2008 Ben Franklin Emerging Business Awards 2SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT 2SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT 3Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings 2Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings 3Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings 4
(Date:11/23/2009)... The time of day matters to forest trees dealing w...a research team led by Professor Malcolm Campbell,...l for research and colleagues in the department of.... , Capitalizing on their previous work to dec...am examined how poplar trees use their 45,000 gene...
(Date:11/23/2009)...0 participants gathered this week for the seventh ...conference. This year,s topic, "Synthetic Biology,...cal researchers to explore the engineering, scient...ield of synthetic biology. , Bonnie L. Bassler, ...sity and this year,s conference chair, challenged ...
(Date:11/23/2009)... provides "incontrovertible evidence" that the vol...tra about 73,000 years ago deforested much of cent...searchers report. , The volcano ejected an estim...re, leaving a crater (now the world,s largest volc...meters wide. Ash from the event has been found in ...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Operation Rescue 3A Wesley Medical Center Promises To Keep Carhart Abortions Out 54579 1Operation Rescue 3A Wesley Medical Center Promises To Keep Carhart Abortions Out 54579 2ULURU Inc Reports Second Quarter 2009 Financial Results 54576 1ULURU Inc Reports Second Quarter 2009 Financial Results 54576 2ULURU Inc Reports Second Quarter 2009 Financial Results 54576 3ULURU Inc Reports Second Quarter 2009 Financial Results 54576 4ULURU Inc Reports Second Quarter 2009 Financial Results 54576 5ULURU Inc Reports Second Quarter 2009 Financial Results 54576 6ULURU Inc Reports Second Quarter 2009 Financial Results 54576 7Senetek PLC Reports Second Quarter 2009 Financial Results 54573 1Senetek PLC Reports Second Quarter 2009 Financial Results 54573 2Senetek PLC Reports Second Quarter 2009 Financial Results 54573 3Senetek PLC Reports Second Quarter 2009 Financial Results 54573 4Senetek PLC Reports Second Quarter 2009 Financial Results 54573 5Senetek PLC Reports Second Quarter 2009 Financial Results 54573 6
...al Center have, for the first time, identified hum...tes that these cells are likely responsible for th...asis that define this deadly cancer. , In the Febr...emonstrate that only 100 of these stem cells are n...f mice tested. They also found these cells are at ...
...ed to developing severe depression, but researche...w, a specific region rife with promise has been l...rchers working under Douglas Levinson, MD, profes... Stanford University School of Medicine. , "This f...covery of a gene that could yield important infor...
...ty of a plant enzyme, researchers at the U.S. Depa...have converted an unsaturated oil in the seeds of ...ly found in tropical plants. The research will be ...l Academy of Sciences (PNAS) the week of March 5, ...an oil with increased saturated fatty acid levels ...
Other Biology News:Scientists identify pancreatic cancer stem cells 2Scientists identify pancreatic cancer stem cells 3Stanford-led study closes in on genes that may predispose some people to severe depression 2Stanford-led study closes in on genes that may predispose some people to severe depression 3New success in engineering plant oils 2New success in engineering plant oils 3
...ters are stored within neurons in vesicles called ...e synaptic bouton. Synaptosomes may be centrifuge...malites in neurotransmitter release have been prop...f release may be studied in isolated synaptosome p...
... Non-Radioactive Translation Detection Systems all...ed in vitro. Using these systems, biotinylated lys...s during translation, eliminating the need for lab...mino acids. This biotinylated lysine is added to t...
...ybridization chambers with forced convection Temp... / 212 F Patented APT.line preheating chamber ass...s DS controller Timer 0 to 24 h Digital tempera...ee Independent adjustable temperature safety devi...
...value of your microarray data using Asuragens bioi...d from consultation to extensive data analysis usi...ise in combination with the Gene Expression Profil...s., ,Normalization and basic statistical analy...
Biology Products: